Yungjin Pharm Rises 5.84% Amid Immune Checkpoint Inhibitor Theme Uptrend

On the 19th, the immuno-oncology theme showed strength by rising 3.07% compared to the previous day, with Yeongjin Pharmaceutical, a related stock, soaring 5.84%. Yeongjin Pharmaceutical is known as a KT&G-affiliated specialty pharmaceutical company focusing on prescription drugs.

[Graph] Price Fluctuations of Major Stocks in the Immuno-Oncology Theme

According to provisional data compiled at 12:41, foreigners are net buying 62,000 shares of Yeongjin Pharmaceutical.

[Table] Net Trading Volume by Foreigners and Institutions (Unit: 10,000 shares)

According to the analysis by Thinkpool Robo Algorithm RASSI, Yeongjin Pharmaceutical ranks 8th out of 26 stocks in the quant financial ranking by exceeding the theme’s average scores in growth, stability, and profitability. This can be interpreted as Yeongjin Pharmaceutical having relatively high investment attractiveness compared to other stocks within the theme from a financial perspective.

[Table] Top Stocks by Financial Scores within the Theme

※ The quant financial score is the result of the Robo Algorithm’s analysis based on each company’s sales growth rate, equity growth rate, debt ratio, current ratio, ROA, ROE, and other factors.

※ This article was generated in real-time by an automated article generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.

This content was produced with the assistance of AI translation services.